Papers/PMID:38904978
Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis.
Critical care explorations2024The record
1 finding drawn from this paper, on 1 compound across 1 endpoint.
What it reported
How to read these marksWhat moved
1 finding
methylene blue — decreases all-cause mortality
Well establishedGrade A, Well established. Replicated human trial evidence, consistent direction.Finding“We found that MB may reduce short-term mortality in patients with septic shock (RR 0.66 [95% CI, 0.47–0.94]), based on low-certainty evidence, downgraded for imprecision and risk of bias among the included trials.”
Quoted verbatim from Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis.. - Study
- meta-analysis
- Participants
- 260
- Population
- critically ill adults with septic shock; short-term mortality horizon, longest reported up to 60 d or in-hospital
Effect 0.66 risk ratio, 95% CI 0.47 to 0.94
Methylene Blue in Septic Shock: A Systematic Review and Meta-Analysis.2024PMID:38904978